Recall: Spacelabs Healthcare Pulls Anesthesia Workstations over Excess CO2 Risk

Wed, 03/27/2013 - 4:33pm
Mass Device

The FDA puts its highest-risk label on Spacelabs Healthcare's anesthesia workstation recall over concerns that a defect resulting in excess carbon dioxide concentration in inhaled gas may lead to patient harm or even death.

Washington-based Spacelabs Healthcare recalled a slate of its Spacelabs BleaseSirius and BleaseFocus anesthesia workstations as well as certain absorbers contained in service kits over concerns that they may contain a defect which could result in excess carbon dioxide in the gas delivered to a patient.

The FDA slapped the recall with Class I status, generally reserved for the highest-risk device defects, over concerns that excess carbon dioxide inhalation "may cause serious adverse health consequences, including death."


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.